Podcast Pearl: Expert Answers to HCP Questions on Pancreatic Cancer Treatment: Podcast Pearls

In this downloadable PDF transcript from a CCO podcast, Michael J. Pishvaian, MD, PhD, and Rachna T. Shroff, MD, answer audience questions from a live CCO webinar focused on current best practices and emerging strategies in pancreatic cancer treatment.
Michael J. Pishvaian, MD, PhD
Rachna Shroff, MD
Format: Adobe Acrobat (.pdf)
File Size: 320 KB
Released: March 22, 2021


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Bristol-Myers Squibb
Ipsen Biopharmaceuticals, Inc.

Related Content

Download slides from Clinical Care Options (CCO) in which experts provide multidisciplinary insights on the use of checkpoint inhibitors for HCC

Lipika Goyal, MD Amit G. Singal, MD, MS Released: April 30, 2021

In this slideset from Clinical Care Options (CCO), experts discuss their thoughts on the use of regorafenib and TAS-102 for colorectal cancer (CRC).

person default Joleen Hubbard, MD John L. Marshall, MD Released: April 29, 2021

Steven Waguespack, MD, on hypothyroidism after immune checkpoint inhibitors, MIBG treatment, or mitotane, and the mechanism of hyperthyroidism in cancer survivors from Clinical Care Options (CCO)

Steven G. Waguespack, MD Released: April 26, 2021

Laurie Cohen, MD, on when and how to retest for GH deficiency, how soon to start GH replacement in cancer survivors from Clinical Care Options (CCO)

Laurie E. Cohen, MD Released: April 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.